PNC Financial Services Group
TENX icon

PNC Financial Services Group’s Tenax Therapeutics TENX Stock Holding History

PNC Financial Services Group’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Hold
0
– -$22 – 4819
2022
Q4 		– Sell
-125
Closed -$27.5K – 4740
2022
Q3 		$34K Hold
125
– – ﹤0.01% 3188
2022
Q2 		$60K Hold
125
– – ﹤0.01% 2875
2022
Q1 		$162K Hold
125
– – ﹤0.01% 2406
2021
Q4 		$208K Buy
125
+81
+184% +$182K ﹤0.01% 2231
2021
Q3 		$124K Buy
+44
New +$115K ﹤0.01% 2494
2014
Q4 		– Hold
0
– -$2K – 4251
2014
Q3 		– Hold
0
– – – 3695

Other funds holding TENX

Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
APP
Avantax Planning Partners Dubuque, Iowa $3.64B AUM 14.73% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PNC Financial Services Group's TENX Position: Q1 2023 in Review

PNC Financial Services Group held its Tenax Therapeutics (TENX) position steady in Q1 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4819.

PNC Financial Services Group first reported a position in TENX in Q3 2021 and has held it in 5 quarters since. The position peaked at $208K in Q4 2021. 10 funds tracked by Wall St. Rank hold TENX as of Q1 2023.

  • PNC Financial Services Group held 0 shares of Tenax Therapeutics worth $0 as of Q1 2023.
  • PNC Financial Services Group left its Tenax Therapeutics share count unchanged in Q1 2023.
  • Tenax Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2023, its #4819 holding.
  • PNC Financial Services Group first reported a position in Tenax Therapeutics in Q3 2021 and has held it in 5 quarters since.
  • PNC Financial Services Group's Tenax Therapeutics position peaked at $208K in Q4 2021.
  • 10 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2023.

Based on PNC Financial Services Group's 13F filing for Q1 2023, filed 15 May 2023.